A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Allergy and Clinical Immunology

• Publication date

  2014-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.jaci.2013.10.048PMID 24373353PMCID PMC3960328
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IL-31 is produced by the malignant T-cell population in cutaneous T-Cell lymphoma and correlates with CTCL pruritus.

  2013cited by this paper
• Activity-dependent silencing reveals functionally distinct itch-generating sensory neurons

  2013cited by this paper
• The Ion Channel TRPA1 Is Required for Chronic Itch

  2013cited by this paper
• New insights into the mechanisms of itch: are pain and itch controlled by distinct mechanisms?

  2013cited by this paper
• TRPA1 controls inflammation and pruritogen responses in allergic contact dermatitis

  2013cited by this paper
• The Cells and Circuitry for Itch Responses in Mice

  2013cited by this paper
• Clinical practice. Chronic pruritus.

  2013cited by this paper
• Controlled-rate freezer cryopreservation of highly concentrated peripheral blood mononuclear cells results in higher cell yields and superior autologous T-cell stimulation for dendritic cell-based immunotherapy

  2012cited by this paper
• A subpopulation of nociceptors specifically linked to itch

  2012cited by this paper
• IL-31 expression by inflammatory cells is preferentially elevated in atopic dermatitis.

  2012cited by this paper
• Pruritus in cutaneous T-cell lymphoma: a review.

  2012cited by this paper
• Evaluation and management of a patient with chronic pruritus.

  2012cited by this paper
• Role of transient receptor potential ankyrin subfamily member 1 in pruritus induced by endothelin-1.

  2011cited by this paper
• Staphylococcal α-Toxin Induces a Higher T Cell Proliferation and Interleukin-31 in Atopic Dermatitis

  2011cited by this paper
• Functional effects of interleukin 31 in human primary keratinocytes

  2011cited by this paper
• Atopic dermatitis: a disease of altered skin barrier and immune dysregulation

  2011cited by this paper
• Variation in NOD2 Augments Th2- and Th17 Responses to Myelin Basic Protein in Multiple Sclerosis

  2011cited by this paper
• TRPA1 is required for histamine-independent, Mas-related G protein-coupled receptor-mediated itch

  2011cited by this paper
• Facial injections of pruritogens and algogens excite partly overlapping populations of primary and second-order trigeminal neurons in mice.

  2010cited by this paper
• MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4.

  2010cited by this paper
• Definition and Characterization of an Inhibitor for Interleukin-31*

  2010cited by this paper
• The multiple pathways for itch and their interactions with pain.

  2010cited by this paper
• Dissociation of the opioid receptor mechanisms that control mechanical and heat pain.

  2009cited by this paper
• Activation of Superficial Dorsal Horn Neurons in the Mouse by a PAR-2 Agonist and 5-HT: Potential Role in Itch

  2009cited by this paper
• Distinct subsets of unmyelinated primary sensory fibers mediate behavioral responses to noxious thermal and mechanical stimuli

  2009cited by this paper
• Multiparametric analysis of cytokine-driven human Th17 differentiation reveals a differential regulation of IL-17 and IL-22 production.

  2009cited by this paper
• TRPV1-expressing primary afferents generate behavioral responses to pruritogens via multiple mechanisms

  2009cited by this paper
• Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus.

  2009cited by this paper
• Cytokine-Producing Dendritic Cells in the Pathogenesis of Inflammatory Skin Diseases

  2009cited by this paper
• Anti‐interleukin‐31‐antibodies ameliorate scratching behaviour in NC/Nga mice: a model of atopic dermatitis

  2009cited by this paper
• Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin.

  2008cited by this paper
• CpG methylation of the IFNG gene as a mechanism to induce immunosuppression [correction of immunosupression] in tumor-infiltrating lymphocytes.

  2008cited by this paper
• Profound reduction of somatic and visceral pain in mice by intrathecal administration of the anti‐migraine drug, sumatriptan

  2008cited by this paper
• Atopic dermatitis.

  2008cited by this paper
• Behavioral differentiation between itch and pain in mouse

  2008cited by this paper
• Immunostimulatory Sequence CpG Elicits Th1-Type Immune Responses in Inflammatory Skin Lesions in an Atopic Dermatitis Murine Model

  2008cited by this paper
• A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses

  2008cited by this paper
• CpG Methylation of the IFNG Gene as a Mechanism to Induce Immunosupression in Tumor-Infiltrating Lymphocytes1

  2008cited by this paper
• A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord

  2007cited by this paper
• Production of dissociated sensory neuron cultures and considerations for their use in studying neuronal function and plasticity

  2007cited by this paper
• Neuronal control of skin function: the skin as a neuroimmunoendocrine organ.

  2006cited by this paper
• Neurophysiological, neuroimmunological, and neuroendocrine basis of pruritus.

  2006cited by this paper
• Cytokines and chemokines orchestrate atopic skin inflammation.

  2006cited by this paper
• IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis.

  2006cited by this paper
• Complete overlap of interleukin-31 receptor A and oncostatin M receptor beta in the adult dorsal root ganglia with distinct developmental expression patterns.

  2006cited by this paper
• IL-31: a new link between T cells and pruritus in atopic skin inflammation.

  2006cited by this paper
• Involvement of IL‐31 on scratching behavior in NC/Nga mice with atopic‐like dermatitis

  2006cited by this paper
• Topical Superantigen Exposure Induces Epidermal Accumulation of CD8+ T Cells, a Mixed Th1/Th2-Type Dermatitis and Vigorous Production of IgE Antibodies in the Murine Model of Atopic Dermatitis1

  2005cited by this paper
• ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model

  2005cited by this paper
• Oncostatin M in the development of the nervous system

  2005cited by this paper
• Role of Mitogen-Activated Protein Kinase Activation in Injured and Intact Primary Afferent Neurons for Mechanical and Heat Hypersensitivity after Spinal Nerve Ligation

  2004cited by this paper
• Predominant expression of the long isoform of GP130-like (GPL) receptor is required for interleukin-31 signaling.

  2004cited by this paper
• Human thymic stromal lymphopoietin promotes dendritic cell–mediated CD4+ T cell homeostatic expansion

  2004cited by this paper
• Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice

  2004cited by this paper
• Proteinase-Activated Receptor-2 Mediates Itch: A Novel Pathway for Pruritus in Human Skin

  2003cited by this paper
• Atypical expansion in mice of the sensory neuron-specific Mrg G protein-coupled receptor family

  2003cited by this paper
• Human Thymic Stromal Lymphopoietin Preferentially Stimulates Myeloid Cells1

  2001cited by this paper
• Cutting Edge: The Orphan Chemokine Receptor G Protein-Coupled Receptor-2 (GPR-2, CCR10) Binds the Skin-Associated Chemokine CCL27 (CTACK/ALP/ILC)1

  2000cited by this paper
• Up-Regulation of Macrophage Inflammatory Protein-3α/CCL20 and CC Chemokine Receptor 6 in Psoriasis1

  2000cited by this paper
• Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial. The Altered Peptide Ligand in Relapsing MS Study Group.

  2000cited by this paper
• Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial

  2000cited by this paper
• Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism

  2000cited by this paper
• Mucosal T lymphocyte numbers are selectively reduced in integrin alpha E (CD103)-deficient mice.

  1999cited by this paper
• Diagnostic criteria for atopic dermatitis: consider the context.

  1999cited by this paper
• Specific C-Receptors for Itch in Human Skin

  1997cited by this paper

• Transient Receptor Potential (TRP) Channels as Fundamental Regulators of Fibrosis and Pruritus—A New Therapeutic Target for Pathological Scar Management

  2026cites this paper
• Low‐Power Short‐Pulse‐Width Fractional Microneedle Radiofrequency Relieves LL37‐Induced Rosacea‐Like Skin Inflammation

  2026cites this paper
• Neuro-immune Crosstalk in Atopic Dermatitis: A Multiaxial Regulatory Network and Novel Therapeutic Perspectives

  2026cites this paper
• Discovery of an Adaptive Neuroimmune Response Driving Itch and Fast Tick Removal with Implications for Preventing Pathogen Transmission.

  2026cites this paper
• Enigmatic Role of IL-31 in the Itch and Inflammation of Vernal Keratoconjunctivitis

  2026cites this paper
• From neuroimmune circuits to targeted therapy of chronic pruritus

  2026cites this paper
• Time‑resolved multi-omic analysis of paclitaxel exposure in human iPSC‑derived sensory neurons unveils mechanisms of chemotherapy‑induced peripheral neuropathy

  2026cites this paper
• Nemolizumab for chronic pruritus beyond atopic dermatitis and prurigo nodularis: a systematic review and synthesis of emerging evidence.

  2026cites this paper
• Cross-Talk between Neurons and Immune Cells in Pruritus: from Mechanisms To Medicines

  2026cites this paper
• Chronic pain without persistent inflammation in an LL-37–induced interstitial cystitis/painful bladder syndrome model: Analgesic effects of a sulfated glycosaminoglycan ether

  2026cites this paper
• Thymic stromal lymphopoietin (TSLP) - pro-inflammatory cytokine and antimicrobial peptide.

  2026cites this paper
• Hyperactivation of sympathetic nerves fuels basophil infiltration in atopic dermatitis.

  2026cites this paper
• The stem of Schisandra chinensis and Schisandrin B alleviated DNCB-induced atopic dermatitis in mice by inhibiting the NF-κB pathway

  2026cites this paper
• The neuroimmune axis: Integrating two systems to decipher itch.

  2026cites this paper
• The neuro-immune insights of itch: peripheral mechanisms and central glial contributions

  2026cites this paper
• Neuronal pentraxin 2 in peripheral sensory neurons drives chronic itch through potentiation of the interleukin-31/interleukin-31 receptor pathway in atopic dermatitis.

  2026cites this paper
• Progesterone- and deoxycorticosterone-derived GABAergic neurosteroids induce itch-related scratching behavior in mouse model of atopic dermatitis

  2025cites this paper
• Assessment of interleukin-31 and immunoglobulin E serum levels in psoriasis with and without pruritic symptoms and their correlations with disease severity

  2025cites this paper
• Emerging trends and research hotspots in atopic dermatitis-related itch over the past 10 years: a bibliometric and visual analysis

  2025cites this paper
• The sensory neuroimmune frontier.

  2025cites this paper
• Evolving Evidence in the Neural Sensitization of Prurigo Nodularis.

  2025cites this paper
• Prevalence and Mechanisms of Itch in Chronic Wounds: A Narrative Review

  2025cites this paper
• Epidemiological, Clinical and Therapeutic Aspects of Atopic Dermatitis in the Dermatovenerology Department of the National References University Teaching Hospital of N’Djamena (Chad): About 103 Cases

  2025cites this paper
• Keratinocytes: new perspectives in inflammatory skin diseases.

  2025cites this paper
• Gut microbes–spinal connection is required for itch sensation

  2025cites this paper
• Role of specialized sensory neuron subtypes in modulating peripheral immune responses.

  2025cites this paper
• Neural-Inflammation Mechanism of Spinal Palmitic Acid Promoting Atopic Dermatitis in Mice

  2025cites this paper
• The impact of cellular infiltration on pruritus in chronic spontaneous urticaria and the updated treatments: A narrative review

  2025cites this paper
• Exosomes: A Promising Cell-Free Therapeutic Tool for Treating Cutaneous Nerve Injuries and Promoting Wound Healing

  2025cites this paper
• Cross-regulation between the nervous system and type 2 immunity.

  2025cites this paper
• Endotypes of Atopic Dermatitis.

  2025cites this paper
• Maladaptive immunity to the microbiota promotes neuronal hyperinnervation and itch via IL-17A.

  2025cites this paper
• The Neuroimmune Axis in Atopic Dermatitis: From Pathogenic Mechanisms to Targeted Neuroimmunotherapy

  2025cites this paper
• Pathophysiologic Mechanisms and Targeted Treatments Associated with the Nervous System in Cutaneous Allergic Diseases

  2025cites this paper
• IL-31-targeting and other novel drugs in itch.

  2025cites this paper
• Rapid improvement of itch with nemolizumab in atopic dermatitis and prurigo nodularis phase 3 studies.

  2025cites this paper
• Assessment of IL-13, IL-31 Levels and Disease Severity in Children with Atopic Dermatitis

  2025cites this paper
• Modulatory effects of bioactive natural compounds on pruritic pathways: mechanistic basis and therapeutic prospects

  2025influential citation
• Therapeutic advances in pruritus as a model of personalized medicine

  2025cites this paper
• Approach to topical treatment of mild-to-moderate atopic dermatitis: A physician assistant perspective

  2025cites this paper
• Beyond Staphylococcus: The Cutaneous Microbiome in Itch Pathobiology

  2025cites this paper
• Real-World, Single-Center Analysis of Cutaneous Adverse Events with Nemolizumab: Toward Safer and More Effective Use

  2025cites this paper
• Neuroimmune interactions between itch neurons and skin microbes.

  2025cites this paper
• Nemolizumab Demonstrates Marked Efficacy in Challenging Chronic Pruritus: A Real-world Multicenter Case Series.

  2025cites this paper
• The Complex Epidermal and Dermal Milieu of M2 Macrophages/IL-31/IL-31RA Network May Play a Role in Keloid Associated Pruritus

  2025cites this paper
• Subcutaneous Injection and Brush Application of Ovalbumin–Aluminum Salt Solution Induces Dermatitis-like Changes in Mice

  2025cites this paper
• Real-World Evidence Demonstrating Nemolizumab's Rapid Efficacy in Recalcitrant Uremic Pruritus

  2025cites this paper
• Mast cell–neuron axis as a core mechanism in chronic pruritus of atopic dermatitis: from mechanistic insights to therapeutic targets

  2025cites this paper
• Characterization and targeting of the endosomal signaling of the gastrin releasing peptide receptor in pruritus

  2025cites this paper
• Febrile temperature-regulated TRPV1 in CD4+ T cells mediates neuroinflammation in complex febrile seizures

  2025cites this paper
• Inflammation-Driven Molecular Ageing in Chronic Inflammatory Skin Diseases: Is There a Role for Biologic Therapies?

  2025cites this paper
• Dupilumab, a Novel Treatment for Peripheral Neuropathy: A Case Series

  2025cites this paper
• Identification of shared and unique mechanisms of atopic dermatitis and ulcerative colitis by construction and computational analysis of disease maps

  2025cites this paper
• Discovery of an Adaptive Neuroimmune Response Driving Itch and Fast Tick Removal with Implications for Preventing Pathogen Transmission

  2025cites this paper
• The Central Role of Th2 Immune Response in Inflammatory Dermatoses: From Pathogenesis to Targeted Therapies

  2025cites this paper
• Experience With Janus Kinase Inhibitors in Acquired Perforating Dermatosis in Older Adults: A Case Series and Review of Literature

  2025cites this paper
• Breaking the Itch-Scratch Cycle: An Integrative Approach for Atopic Dermatitis.

  2025cites this paper
• Lichen Simplex Chronicus: Clinical Perspectives and Emerging Therapeutic Strategies

  2025cites this paper
• Imperatorin activates TRPV1/GRPR pathway to induce scratching behaviors in mice.

  2025cites this paper
• Type 2 cytokines pleiotropically modulate sensory nerve architecture and neuroimmune interactions to mediate itch.

  2025cites this paper
• Use of Nemolizumab in Refractory Scrotal Dysesthesia.

  2025cites this paper
• Pruritus and Neuropsychiatric Symptoms Among Patients with Darier Disease—An Overlooked and Interconnected Challenge

  2025cites this paper
• Use of bidirectional Mendelian randomization to unveil the association between antibody-mediated immune responses to infectious agents and allergic rhinitis

  2025cites this paper
• Evaluation of One-Time Oral Oclacitinib Administration on Pruritic Behaviours After Intradermal Interleukin-31-Induced Pruritus Injections ("Reactive" Model) in Healthy Dogs: A Blinded, Randomised, Cross-Over Study.

  2025cites this paper
• The roles of transient receptor potential vanilloid in autoimmune diseases.

  2025cites this paper
• Itching Sensation and Elevated Interleukin‐31 Levels as Potential Indicators of Exceptional Response to Biologics in Patients With Moderate‐To‐Severe Psoriasis

  2025cites this paper
• Benralizumab Depletes IL‐5Rα‐Bearing Cells in Skin Lesions of Patients With Atopic Dermatitis

  2025cites this paper
• Preliminary Observation of Tofacitinib in the Treatment of Primary Cutaneous Amyloidosis: A Single-Arm Clinical Trial.

  2025cites this paper
• Antigen-presenting cells orchestrate mixed inflammatory endotypes in atopic dermatitis.

  2025cites this paper
• Itch

  2025cites this paper
• Decoding Allergic Conjunctivitis: Latest Perspectives on Etiological Drivers and Immunopathological Mechanisms

  2025cites this paper
• Symptom clusters and sentinel symptoms during post-transplant recovery in recipients of allogeneic hematopoietic stem cell transplantation: A cross-sectional study

  2025cites this paper
• Early itch relief with ivarmacitinib improves quality of life, working productivity, and sleep quality in patients with moderate-to-severe atopic dermatitis: a post hoc analysis of a phase III trial

  2025cites this paper
• Deciphering the causal effect of metabolic syndrome and its components on pruritus: Evidence from Mendelian randomization study

  2025cites this paper
• Structural insights into IL-31 signaling inhibition by a neutralizing antibody.

  2025cites this paper
• Basic Mechanisms of Itch and Advances in Clinical Management.

  2025cites this paper
• Neuropharmacology and physiology of human dorsal root ganglion neurons responsible for nociception: state-of-the-art and future directions.

  2025cites this paper
• IL-31/33 Axis in Atopic Dermatitis

  2025cites this paper
• Neuroimmune mechanisms of type 2 inflammation in the skin and lung.

  2025cites this paper
• Discovering the role of sulfur against atopic dermatitis via the AC010336.1/miR-3929/GPI axis with a machine-learning power.

  2025cites this paper
• Sensory neuronal mTORC1 signaling establishes neuroimmune memory that initiates allergic immunity

  2025cites this paper
• Comparative safety profiles of dupilumab and nemolizumab in prurigo nodularis: an indirect META-analysis to inform clinical decision-making

  2025cites this paper
• Ruxolitinib Cream Demonstrated Rapid Reductions in Itch and Atopic Dermatitis Signs That Correlated With Biomarkers.

  2025cites this paper
• Updates on kinase inhibitors in allergy.

  2025cites this paper
• Multi-Omics Reveals CCL3 Driving Neuronal Sensitization in Chronic Pruritus of Unknown Origin.

  2025cites this paper
• IL-2/IL-2Rβγ signaling in pruriceptors drives neuroimmune mechanisms of nivolumab-induced persistent itch

  2025cites this paper
• Neurogenic inflammation and itch in barrier tissues.

  2025cites this paper
• Maladaptive changes in the homeostasis of AEA-TRPV1/CB1R induces pain-related hyperactivity of nociceptors after spinal cord injury

  2025cites this paper
• Evaluating duloxetine for pruritus and psychiatric comorbidities in lichen simplex chronicus

  2025cites this paper
• Eficácia e segurança da fototerapia com ultravioleta B de banda estreita em prurigo nodular: experiência de um centro terciário

  2025cites this paper
• Investigation of the participation of the TRPV1 receptor in the irritant effect of dithranol in mice.

  2025cites this paper
• Biosynthesis inhibition of miR-142-5p in a N6-methyladenosine-dependent manner induces neuropathic pain through CDK5/TRPV1 signaling

  2025cites this paper
• Type 2 immunity in allergic diseases

  2025cites this paper
• Neuroimmune Circuits in Allergic Diseases.

  2025cites this paper
• Host–Microbiome Interactions in Chronic Itch

  2025cites this paper
• Basophils Activate Oncostatin M Receptor-expressing Vagal Sensory Neurons.

  2025cites this paper
• Cancer Therapy-induced Dermatotoxicity as a Window to Understanding Skin Immunity.

  2024cites this paper
• IL‐4 and IL‐13 are not involved in IL‐31‐induced itch‐associated scratching behaviour in mice

  2024cites this paper
• Monoclonal antibodies for moderate-to-severe atopic dermatitis: a look at phase III and beyond

  2024cites this paper
• First line therapy for multiple sclerosis: cytokine levels and the impact of herpesvirus infection

  2024cites this paper